Karak buy cocaine

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Karak buy cocaine

Citation: Abdeen M. Omer, al, , Counterfeiting drugs set alarm bells ringing: Comparative analysis of drug policies, J. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies Public Corporation CMS. In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low-quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conducts. The World Health Organisation WHO, has defined drug regulation as a process, which encompasses various activities, aimed at promoting and protecting public health by ensuring the safety, efficiency and quality of drugs, and appropriateness accuracy of information WHO, Medicines regulation is a key instrument employed by many governments to modify the behaviour of drug systems. The regulation of pharmaceuticals relates to control of manufacturing standards, the quality, the efficacy and safety of drugs, labelling and information requirements, distribution procedures and consumer prices Sibanda, The manufacturing, registration and sale of drugs have been the subject of restricts regulations and administrative procedures worldwide for decades Lofgren, and Boer, No set of regulations could achieve that goal, because it is impossibility and all drugs carry some risk Lexchin, Stringent drug regulation was introduced across many countries in the s following the thalidomide disaster, and had since been embraced by the industry as a commercial essential seal of safety and quality Lofgren, and Boer, In spite of the measures, many countries, especially developing ones face a broader range of problems. In several developing countries drug quality is a source of concern. There is a general feeling there is a high incidence of drug preparations, which are not of acceptable quality Shakoor, Taylor, and Behrens, Hence, it is very difficulty to obtain an accurate data. The proportion of drugs in the USA marketplace are counterfeit is believed to be small - less than 1 percent Rudolf, and Bernstein, Andalo, reported two cases of counterfeit medicines found their way into legitimate medicine supply chain in the UK in Poor quality drug preparations may lead to adverse clinical results both in terms of low efficacy and in the development of drug resistance Shakoor, Taylor, and Behrens, Regulations are the basic devices employed by most governments to protect the public health against substandard, counterfeit, low quality medicines, and to control prices. Thus, thorough knowledge of whether these regulations produce the intended effects or generate unexpected adverse consequences is therefore critical. The World Health Organisation WHO undertook a number of initiatives to improve medicines quality in its member states and promote global mechanisms for regulating the quality of pharmaceutical products in the international markets. There are numerous reports concerning drug regulations Ratanwijitrasin, Soumerai, and Weerasuriya, , but the published work on the impact of these regulations on the quality of medicines moving in the international commerce has been scarce. Findings from most published studies lack comparable quantitative information that would allow for objective judging whether and by how much progress on the various outcomes have been made by the implementation of the pharmaceutical regulations. To ignore evaluations and to implement drug regulation based on logic and theory is to expose society to untried measures in the same way patients were exposed to untested medicines Ratanwijitrasin, Soumerai, and Weerasuriya, The present policy of the national health—care system in Sudan is based on ensuring the welfare of the Sudanese inhabitants through increasing national production and upgrading the productivity of individuals. A health development strategy has been formulated in a way that realises the relevancy of health objectives to the main goals of the national development plans. The strategy of Sudan at the national level aims at developing the Primary Health Care PHC services in the rural areas as well as urban areas. In Sudan physicians provide the public health services specialists, medical registrars, medical officers, dentists, and pharmacists Gamal and Omer, Methods of preventing and controlling health problems are the following:. This will be achieved through a health system consisting of three levels state, provincial and localities , including the referral system, secondary and tertiary levels. Pharmacy management should be coordinated and integrated with other various aspects of health. The following are recommended:. The health system in Sudan is characterised by heavily reliance on charging users at the point of access private expenditure on health is The way the health system is funded, organised, managed and regulated affects health workers' supply, retention, and the performance. Primary Health Care was adopted as a main strategy for health-care provision in Sudan and new strategies were introduced during the last decade, include:. The investment law approved recently has good statements and rules on the above strategy in particular to health and pharmacy areas. The privatisation and price liberalisation in healthy fields has to re-structure but not fully. Availability and adequate pharmacy supplies to the major sectors. The result is that, the present situation of pharmacy services is far better than ten years ago. The government of Sudan has a great experience in privatisation of the public institutions i. These experiences provide good lessons about the efficiency and effectiveness of the privatisation policy. Through privatisation, government is not evading its responsibility of providing health-care to the inhabitants, but merely shifting its role from being a provider to a regulator and standard setter. The drug financing was privatised early in Currently, the Federal Ministry of Health FMOH has privatised certain non-medical services in hospitals such as catering services, security and cleanings. The overall goal of the CMS ownership privatisation is to improve access to essential medicines and other medical supplies in order to improve health status of the inhabitants particularly in far states e. Establishment of alternative ownership for the CMS can be achieved by selling the majority of shares to the private sector. This will achieve the following objectives:. The term privatisation has generally been defined as any process aims to shift functions and responsibilities totally or partially from the government to the private. In broader meaning, it refers to restrict government's role and to put forward some methods or policies in order to strengthen free market economy Aktan, Privatisation can be an ideology for those who oppose government and seek to reduce its size, role, and costs, or for those who wish to encourage diversity, decentralisation, and choice or a tool of government for those who see the private sector as more efficient, flexible, and innovative than the public sector Kamerman et al. The emphasis is on improving the efficiency of all public enterprises, whether retained or divested. In Sudan, the government has decided to distance itself from direct involvement in business, and thus to divest most of its interests whether in loss- or profit-making public enterprises. The public reform programme was set firmly in the context of the broader reforms, which were introduced in It had become clear the previous policies had delivered very disappointed results. This reform based on the transfer of activities vested with the government institutions to the private sector. It signalled the government intention to reduce its presence in the economy, to reduce the level and scope of public spending and to allow market forces to govern economic activities. Privatisation also forms part of the government strategy of strengthening the role of the private in the development to achieve the vision of the 25 years strategy in which the private sector will be the engine for economic growth. The privatisation started in by liberalization of local currency, foreign exchange transactions, internal and external trade, prices and health services e. This reform had led to greater reliance on individual initiative and corporate accountability rather than on government as a decision-maker in business matters. The privatisation policy goal is to improve the performance of the public sector companies. So, they can contribute to the growth and the development of the economy by broadens ownerships, participation in management, and stimulation domestic and foreign private investment. In pursuing the primary objectives, the privatisation policy aims to transform the performance of most significant enterprises in the public sector and ensure liquidation of all viable and non-viable public enterprises as soon as possible through commercialisation, restructuring and divesture. Movement towards those goals in some countries is supported by components of a structural adjustment loan, which helped initiate the programme and establish the legislative and institutional base. Opponents argue, the original objectives of state ownership were to ensure the corporate sector of the economy was in national hands rather than being controlled by either foreign investors or the minorities that enjoyed business dominance upon independence. A further objective was to use investment in state firms to accelerate development in a situation, in which private sector was reluctant to take risks. The availability of medicines in Sudan is controlled on the basis of safety, quality and efficacy. Thus, the government effects control in accordance with the Pharmacy, Poisons, Cosmetics and Medical Devices Act and its instruments. The first Pharmacy and Poisons Act was enacted in This Act had been amended three times since then. In amendments, cosmetics and medical devices were also brought under its purview. The Act regulates the compounding, sale, distribution, supply, dispensing of medicines and provides different levels of control for different categories e. Traditionally, governments in many countries, particularly developed nations have attempted to ensure the efficiency, safety, rational prescribing, and dispensing of drugs through pre-marketing registration, licensing and other regulatory requirements Ratanwijitrasin, Soumerai, and Weerasuriya, When applying to register the medicine manufacturers and importers are required to furnish the FGDOP with a dossier of information including among others, the indication of the medicine, its efficacy, side effects, contraindication, warnings on usage by high-risk groups, price, storage and disposal MOH, In Sub-Saharan Africa countries Sudan is not an exceptional discussions about medicine distribution system reform have concentrated on ways to improve sustainability and quality of access to essential medicines. These discussions also include debate on the impact of privatisation of public drug supply organisations on effectiveness, efficiency, quality and cost of medicines in the public health facilities, as well as on the respective role of the public and private sectors Leighton, Until the mid s, governments in Africa assumed responsibility for providing drugs to the inhabitants in some countries such as Mali and Guinea. The private distribution of all drugs including aspirin was illegal Vogel et al. In many countries e. The public health network of hospitals and health centres were gratuitously distributed drugs. In the public sector pharmacies, the drugs were sold to the public at subsidised prices. During the s, Sudan initiated a number of initiatives to establish drug-financing mechanisms as part of the health reform process and decentralised decision-making at a state level. In when a law was passed, medicines were not anymore free-of-charge i. As a result, the Central Medical Stores, which was responsible for medicines supply system of the public health facilities, became an autonomous drug supply agency, and renamed as the Central Medical Supplies Public Corporation CMS and operated on cash-and-carry basis. It was capitalised and an executive board was installed. Since that time, it implied the states and federal hospitals have to buy their own medicines, other medical supplies. They organised their own transport means and distribution to their primary health-care facilities and hospitals. In addition, all hospitals became financially autonomous entities and had to organise their own medicines procurement system. The public drug supply system has not been working throughout Sub-Saharan Africa including Sudan. There are serious shortages or no medicines at all, particularly in rural areas. Hospitals had to purchase the medicines from elsewhere and often had to buy from private sector. This resulted the medicines were not available most of the times. The in- or outpatients with their prescriptions were directed to the private pharmacies. This would not fill one prescription for an anaemic patient as a result of renal failure. This is a common practice that patients or their relatives are given prescriptions to buy any pharmaceutical supplies that are needed including drugs and other disposables from private sector pharmacies. These characteristics include:. Competition is the best way to ensure the goods and services desired by the consumer are provided at the lowest economic cost. Given the customers i. Privatised companies generally operate in a competitive market environment. For example, in Sudan with exception of Khartoum, Gezira and Gedaref states, all the states have no enough funds to establish efficient drug supply system. In spite of being profit-making organisation, the CMS failed to avail such funds during the past 14 years. The CMS since it was established in early s working as a profit-making organisation. Such amount could be sufficient to establish a reliable supply system for all states of Sudan. The lack of prioritisation is a typical symptom and sign of most public organisations. Managers confront different challenges in public setting. They are not easily hired or fired. The lack of accountability results from the lack of shareholders, who would be free to remove incompetent administrators. In addition, the managers do not share in dividends or other monetary activities as do private managers and incentives for doing well are often attenuated in a bureaucracy. The public sector drug supply institutions have not succeeded CMS is not exceptional so far in organising a reliable and regular essential drug supply for the public health facilities Huss, One of the most criticisms of the public drug supply system generally in Africa and particularly in Sudan, is how badly they are internally managed. There are those who agree the greater amount of real pharmaceutical resources could be made available to the public health- care system and the access to essential medicines could be significantly increased, if managerial efficiency of the system improved Akin, Given the limitation of the public sector - due to constraints inherent in operating a government drug supply organisation even after autonomous experience - and the stabilised role of the private sector organisations such as private pharmaceutical sectors organisations rapid increase in importing companies, manufacturers and pharmacies. Telecommunications, e. There are many arguments in favour of privatisation of public institutions. Advocates of this method claim privatisation have the following advantages Savas, ; Hartley, ; De Hoog, ; Moore, ; and Ascher, The Act, for the first time in Sudan has given the responsibility of veterinary medicines to separate committees. The conflict in the shared authorities between the Ministry of Health and the chairman of the FPPB lead to the freezing of the Board since October But, the weaknesses of the regulatory infrastructure and lack of political commitment at state levels, the leakage of low quality, unregistered medicines to those states are highly suspected. This left the door widely opened for informal marketing of medicines particularly in far states. The states regulatory authorities should take the advantage of the legal authority granted by the Sudan constitution and the Pharmacy, Poisons, Cosmetics and the Medical Devices Act to enforce the regulations and increase the frequency of the inspection visits to drug companies and retail pharmacies. Experience has shown the poor regulation of medicines can lead to the prevalence of substandard, counterfeit, harmful and ineffective medicines on the national markets and the international commerce. The Sudanese pharmaceutical legal framework was described as one of the strictest pharmaceutical systems in the region. Respondents were hopeful the double standard of rules enforcement would be lifted after the new national unity government take over, arguing the current situation in which public organisations such as the CMSPO sell non-registered medicines to the private pharmacies could enhance trading of counterfeit medicines and create unfair competition environment. During the past three years the CMSPO started to sell unregistered medicines to the private pharmacies. The CMSPO practice he added will undermine the inspection and medicines control activities and ultimately jeopardise the health of the people taking medication. Not surprisingly all respondents strongly agreed the increased number of sources of non-registered medicines will lead to entrance of low-quality medicines. The medicines imported by public sector organisations are not excluded Bryman, The FGDOP should define the norms, standards and specifications necessary for ensuring the safety, efficacy and quality of medicinal products. The availability, accuracy and clarity of drug information can affect the drug use decisions. The FGDOP does not have a well-developed system for pre-approval of medicines labels, promotional, and advertising materials. The terms and conditions under, which licenses to import, manufacture and distribute will be suspended, revoked or cancelled. This should be stringently applied to public, private and not-for-profit NGOs drug supplies organisations. The recent post-marketing study carried by the National Drug Quality Control Laboratories, suggested the power of the current regulation is overestimated WHO, The finding of this article indicates the application procedures of the current measures to ensure the quality of medicines should be revisited. The technical complexity of regulations, political, commercial and social implications, makes necessary a degree of mutual trust between concerned stakeholders i. The study reveals the need for further research to find out how efficient the regulatory authorities at both federal and state levels are. The research also needed to discover whether or not counterfeit medicines are sold on the Sudanese market. Even in the absence of broader adjustment context, however, it has long been clear the CMS reform is needed and indeed is not too avoidable. Patients, administrators at both hospitals and ministries of health , doctors and other health-care professionals, the regulatory authority and others are being fully aware the performance of the CMS is so poor and ill people are really suffered even after the privatisation of medicines financing in The Ministry of Finance after more than 14 years still have to inject annual money to cover the cost of certain budget lines such as free medicines projects. In addition, the following are main three justifications, which summarise the inefficiency of the CMS as a public organisation:. This is not to say the CMS has no future: there are substantial investment opportunities. Many can be turned around under new ownership and will succeed. It has been the experience of state enterprises worldwide that, in both socialist economies and in mixed economies, it is exceedingly difficult to remain competitive:. Reform is a matter of practical necessity rather than ideology. For example, the government of Cuba has still committed to socialist policies, and has recently chosen for pragmatic reasons, to privatise its telephone company. The final pragmatic reason impelling the government towards swift public sector reform is the resources are being misused. It is not surprising some obstacles and resistance from the CMS member of staff will confront this reform. The following strategies will help to overcome such resistance and obstacles:. Private enterprise functions most efficiently if market forces are allowed to operate independently and completely unfettered. Nonetheless, some FMOH involvement is necessary to ensure the availability of proper use of good quality and affordable pharmaceuticals. So FMOH will continue its current responsibility for importing, licensing, inspecting and regulating the distribution system without any discrimination between different organisations including the new established business, facilitating the development of adherence to the national drug list in the public health facilities, encourage purchasing of registered medicines from the least cost reliable sources, quality control of medicines and maintenance of quality through out the system, and enforcement of price control system. The FMOH could also be involved in informing private distributors and the public about the appropriate use of medicines. At the public health facilities, however, freedom-of-choice arguments that would justify a laissez-fair approach to private sector importing do not apply. There is the overriding merit-good aspects of medicines need, the related requisites of availability, cost-efficiency, and quality control. Some pharmaceuticals are more cost-effective than others. Therefore, the enforcement of a government-mandated essential drug list lowers the real resource cost of a given quantity of pharmaceuticals necessary for alleviation of common diseases. Standard treatment guidelines alleviate unsuitable medicating practices particularly over-medication, and reduce costs to consumers. The CMS reform is stronger today than it was in the early s when the reforms were started. There are many highly committed and able individuals throughout the public sector in the absence of the single-minded pursuit of commercial success. Also, in the long-term interest of employment growth and the public at large, narrower concerns have prevailed. Managements and boards are less able and less willing to impose accountability for results on themselves and their employees. Stock-out of life saving items is common, and sanctions for non-performance are often absent altogether. To overcome those common symptoms of all public owned enterprise, and achieve the strategic objectives of the FMOH by increasing the access of population to the essential medicines. By resurrecting competition, which could be achieved mainly through privatisation of the CMS ownership, many of the mentioned pitfalls can be avoided. The new business should be responsible of course without any kind of monopoly for drug supply and distribution to the public health facilities on competition basis. By resurrecting competition, which could be achieved mainly through privatisation of the CMS ownership, many of the mentioned pitfalls can be to avoided. The special share requires certain provisions in the articles of incorporation of a company may not be changed without the specific consent of special shareholder. The presence of a special share is useful tool but is not intended to be a government straitjacket on the management. In order to develop a free market in shares, special shares should be time limited as far as possible. The purpose of privatisation is to remove the government from ownership of the CMS. In some cases, especially where there are major uncertainties about the probable market of the business, for example, United Kingdom and other governments have sold their ownership interest gradually in several times over a period of years Gibbon, ; Bryman, ; MOH, ; and Andalo, Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources. Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all. Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal. Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration. We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal. The peer-review process which consisted high quality queries on the paper. The support from the editorial office is excellent. Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal. Katarzyna Byczkowska My testimonial covering: 'The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field. Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled 'Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update' for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics'. The editorial team has been very supportive. Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal. The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. This journal is one of outstanding medical journal. Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers. As an author who has recently published in the journal 'Brain and Neurological Disorders'. I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site. I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day! We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay'. I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work. We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future. I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells. I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao. Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal. Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time. Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort. Dear Dr. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled 'Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients. I hope we can maintain our scientific relationship in the long term. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future! The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again. Their professionalism is apparent and more than satisfactory. Susan Weiner. Toggle navigation. Explore journals Our Services Reprints and permissions. Submit Guidelines. Quick Links. Received: 24 August Accepted: 18 September Published: 16 October Keywords: sudan; healthcare; medicines; regulatory authorities; pharmacy management. Abstract The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. Methods of preventing and controlling health problems are the following: Promotion of food supply and proper nutrition. An adequate supply of safe water and basic sanitation. Maternal and child health-care. Immunisation against major infectious diseases. Preventing and control of locally endemic diseases, and Provision of essential drugs. The following are recommended: Community must be the focus of benefits accruing from restructures, legislature to protect community interest on the basis of equity and distribution, handover the assets to the community should be examined; and communities shall encourage the transfer the management of health schemes to a professional entity. The private sector should be used to mobilise, and strengthen the technical and financial resources, from within and without the country to implement the services, with particular emphasis on utilisation of local resources. The government should provide the necessary financial resources to guide the process of community management of pharmacy supplies. The government to divert from provision of services and be a facilitator through setting up standards, specifications and rules to help harmonise the private sector and establish a legal independent body by an act of parliament to monitor and control the providers. Government to assist the poor communities who cannot afford service cost, and alleviate social-economic negative aspects of privatisation. The sector actors should create awareness to the community of the roles of the private sector and government in the provision of health and pharmacy services. Support agencies assist with the financial and technical support, the training facilities, coordination, development and dissemination of health projects, and then evaluation of projects. Health and Pharmacy Systems The health system in Sudan is characterised by heavily reliance on charging users at the point of access private expenditure on health is Primary Health Care was adopted as a main strategy for health-care provision in Sudan and new strategies were introduced during the last decade, include: Health area system. Polio eradication in Integrated management of children illness IMCI initiative. Rollback malaria strategy. Basic developmental need approach in Efficiency and effectiveness in drug distribution system to avoid the serious pitfalls and incidences that reported during the last ten years in the CMS. Equity by reaching all remote areas currently deprived from the formal drug distribution channels. Improvement of the quality and quantity of delivery of medicines to the public health facilities. The above objectives are expected to: Increase geographical and economic access to essential medicines in all states i. The tax collection from the new business becomes more efficient and will increase after privatisation. The tax revenues could be used to finance other health-care activities. Privatisation of public pharmaceutical supplies The term privatisation has generally been defined as any process aims to shift functions and responsibilities totally or partially from the government to the private. Privatisation may take many forms including: The elimination of a public function and its assignment to the private sector for financial support as well as delivery police, and fire departments, schools, etc. Deregulation is the elimination of government responsibility for setting standards and rules concerning goods or services Gormley, and Vouchers are the government provided or financed cards or slips of paper that permit private individuals to purchase goods or services from a private provider food stamps or circumscribed list of providers Kettl, Franchising is the establishment of models by the public sector that is funded by government agencies, but implemented by approved private providers. Contracting is the government financing of services, choice of service provider, and specification of various aspects of the services laid out in contracts with the private-sector organisation that produces or delivers the services. User fees are the public facilities such as hospitals maximise their income or finance some goods from private sources, either through drug sales or other services. This kind of privatisation is applied in Sudan since early s, as the health financing mechanism especially for medicines. Expand the role of the private sector in the economy permitting the government to concentrate on the public resources on its role as provider of basic public services, including health, education, social infrastructure, and to compact the side effects of the privatisation. Encourage wider participation of the people in the ownership and management of business. Medicines legislation framework in Sudan The availability of medicines in Sudan is controlled on the basis of safety, quality and efficacy. The role of FGDOP includes among others: Regulation and control of the importation, exportation, manufacture, advertisement, distribution, sale and the use of medicines, cosmetics, medical devices and chemicals; Approval and registration of new medicines - the Act requires FGDOP should register every medicine before be sold or marketed. Control of quality of medicines: This will be done by regular inspection and post-marketing surveillance; Licensing of pharmacy premises i. Public sector medicines supply system In Sub-Saharan Africa countries Sudan is not an exceptional discussions about medicine distribution system reform have concentrated on ways to improve sustainability and quality of access to essential medicines. These characteristics include: 1 Absence of competition: Competition is the best way to ensure the goods and services desired by the consumer are provided at the lowest economic cost. These constraints comprise: a Civil servants are hired, rather than persons with business experience and skills. Advantages of private agencies There are many arguments in favour of privatisation of public institutions. Privatisation is efficient and effective because it fosters and initiates competition. The competition among firms drives the cost down. Empirical studies clearly prove the cost of the services provided by the government is much higher than when the services are provided by private contractors. In addition, private sector pays taxes, customs and other governmental fees CMS exempted. Privatisation also provides better management than the public management. Because decision making under privatisation is directly related to the costs and benefits. In other words, the privatisation fosters good management because the cost of the service is usually obscured. Privatisation would help to limit the size of government at least in terms of the number of employees. On the other hand, it is a fact that overstaffing is common in publicly owned enterprises. Privatisation can help to reduce dependence on a government monopoly, which causes inefficiencies and ineffectiveness in services. Private sector is more flexible in terms of responding to the needs of citizens. Greater flexibility in the use of personnel and equipment would be achieved for short-term projects, part-time work, etc. Bureaucratic formalities are very common when government delivers the service. Less tolerance and strict hierarchy in bureaucracy are the reasons of the inflexibility in publicly provided services. Medicines supply system The Act, for the first time in Sudan has given the responsibility of veterinary medicines to separate committees. From the data obtained in this article some general inferences could be made: The broad outlines remain intact, but preventing drug smuggling across national boarders Sudan shares frontiers with 9 countries is hard to police. The enforcement of the Act and its regulation governing the manufacture, importation, sale, distribution and exportation of medicines are not adequate enough to control the illegal importation and sale of medicines in Sudan. The splitting of the drug regulatory authority between two ministries and the marketing of unregistered medicines by public drug suppliers namely the CMSPO, and RDFs , and NGOs undermine the quality of medicines and ultimately jeopardise the health of the people taking medication. In the light of the findings the following recommendations could be useful at various levels: There is an urgent need for government to implement the provisions of existing Act. The government should adequately equip and fund the National drug Analysis laboratories to start active post-marketing surveillance. They should be adequately funded to be able to acquire the necessary facilities for their operations. The latter practice undermines the inspection outcomes, because it makes inspectors task too difficult i. Rational of the CMS privatisation Even in the absence of broader adjustment context, however, it has long been clear the CMS reform is needed and indeed is not too avoidable. In addition, the following are main three justifications, which summarise the inefficiency of the CMS as a public organisation: There is a widespread dissatisfaction with the situation of pharmaceuticals in public facilities. Yet, the cost has been immense and it is continuing. There is no satisfactory estimate of the total capital invested in the CMS. Rather than receiving a sustained flow of dividends from its investments, the Ministry of Finance still financing the free medicines and certain diseases drugs. In contrast, the CMS pays nothing to health services since it was established in Instead, the strong stream of dividends and tax revenues, which should support public spending on other health activities, is lost. Hence, it is the poor who suffer as a result. Violation of pharmaceutical regulation at the expenses of the public health by creating a big loophole in the pharmaceutical legal framework, which will inevitably lead to marketing of counterfeit medicines. This practice also suppresses the private sector the government encourages it heavily to grow by making inappropriate barriers to the private sector provision of drugs. It has been the experience of state enterprises worldwide that, in both socialist economies and in mixed economies, it is exceedingly difficult to remain competitive: If run by a board of public servants with multiple objectives and without real accountability to shareholders. The constraints from government on investment and other business decisions. If cut off by virtue of ownership from the latest technologies, marketing and management trends. The basic points are: Public sector boards and civil servants are not in touch with markets and commercial trends. Government-run companies have conflicting objectives that do not stress commercial accountability and thus jeopardise survival and commercial success. Strategies to overcome the CMS privatisation obstacles It is not surprising some obstacles and resistance from the CMS member of staff will confront this reform. Promotion research and development, demonstration and dissemination of information for the current situation. WHO mission Report will be of great value and expected outcomes with more focus on the patients after adoption of user fee policy. The role of the FMOH Private enterprise functions most efficiently if market forces are allowed to operate independently and completely unfettered. Akin, J. Financing health services in developing countries: an agenda for reform. World Bank, Washington, D. C: USA. An introduction to the theory of privatisation. Death for sale: A study of drug poisoning and deaths in Nigeria. Counterfeit drugs set alarm bells ringing. Pharmaceutical Journal The politics of privatisation contracting out public services. New York: St Martin's Press. Privatising the Delivery of Social Welfare Services. Privatisation and Welfare State, Eds. Princeton, N. J: Princeton University Press. Social Research Method. Oxford University Press. Contracting out for human services-economic, political and organisational perspectives. New York: State University of Albania. Ali and Abdeen M. A guide for divesting government-owned enterprises. How to Guide. July Regulatory privatisation: a case study. Journal of Public Administration Research and Theory 6 2 : Regulatory Enforcement: Accommodation and conflict in four states. Public Administration Review 37 4 : Privatisation and its Alternative. WHO mission to Sudan: travel report. World Health Organisation: Geneva. Contracting-out: A step towards competition. Economic Affairs 6 5. The role and experience of the World Health Organisation in assisting countries to develop and implement national drug policies. Australian Prescriber 20 Supp. Pharmaceutical consumer co-operative - the third path? World Hospitals 31 3 : Evaluation of national drug policy in the Gambia, with special emphasis on the essential drug programme. University of Oslo: Norway. Privatisation and Welfare State. Privatisation as a tool of reform. The Lafollette Policy Report. Strategies for achieving health-financing reform in Africa. World Development 24 9 : Pharmaceuticals in Australia: developments in regulation and governance. Social Science and Medicine Khartoum: Sudan. Unpublished Report. Contracting-out: A painless alternative to the budget cutter's knife. Steve H. Hankie Ed. Prospect for privatisation. New York: The Academy of political science. Socio-cultural aspects of water supply and sanitation in Sudan. Faking and counterfeiting of drugs. West African Journal of Pharmacy 12 1 : Do national medicinal drug policies and essential drug programmes improve drug use? A review of experiences in developing countries. Counterfeit Drugs. New England Journal of Medicine 14 : Privatisation: The key to better government. Chatham House Publishers Inc. Health Services Privatisation in Industrial Societies. London: Jessica Kingsley Publishers. Assessment of the substandard drugs in developing countries. Tropical Medicines and International Health 2 9 : — Cameroon health centre study. The efficiency of inefficiency: medicine distribution in South Cameroon. Social Science Medicine Availability of pharmaceutical in Sub-Saharan Africa: roles of the public, private and church mission sectors. Social Science Medicine 29 4 : Comparative analysis of international drug policies. Report from the second workshop Geneva. The World Medicines Situation. International drug policies. Geneva: Switzerland. View at Publisher View at Google Scholar. Mina Sherif Soliman Georgy. Anthony Kodzo-Grey Venyo. Gomez Barriga Maria Dolores. Maria Dolores Gomez Barriga. Dr Maria Dolores Gomez Barriga. Dr Maria Regina Penchyna Nieto.